Aminobenzoic acids and derivatives
![eMolecules 169869-90-3 | Exatecan (mesylate) | ChemScene | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 5g | 717419481](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502694816.jpg-250.jpg)
eMolecules 169869-90-3 | Exatecan (mesylate) | ChemScene | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 5g | 717419481
Exatecan (mesylate) | ChemScene | 169869-90-3 | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 5g | 717419481
![eMolecules 169869-90-3 | Exatecan (mesylate) | ChemScene | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 250mg | 536818696](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000128313.jpg-250.jpg)
eMolecules 169869-90-3 | Exatecan (mesylate) | ChemScene | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 250mg | 536818696
Exatecan (mesylate) | ChemScene | 169869-90-3 | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 250mg | 536818696
![eMolecules 169869-90-3 | Exatecan mesylate | Ambeed | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 25mg | 784396074](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000126370.jpg-250.jpg)
eMolecules 169869-90-3 | Exatecan mesylate | Ambeed | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 25mg | 784396074
Exatecan mesylate | Ambeed | 169869-90-3 | MFCD04113012 | 531.560 | C25H26FN3O7S | 98.000 | CS(O)(=O)=O.CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cc(F)c(C)c5CC[C@H](N)c(c3Cn1c2=O)c45 | 25mg | 784396074
eMolecules 106037-36-9 | 4-amino-3-methylbenzamide | MFCD08061918 | 5g
Ambeed | 1-(4-Methoxybenzyl)-4-(4455-tetramethyl-132-dioxaborolan-2-yl)-1H-pyrazole | 1g | 572945307 | A340561 | 1105039-88-0 | MFCD16877287 | 314.190 | C17H23BN2O3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Selleck Chemical LLC 3-Aminobenzamide S1132-25mg
3-Aminobenzamide (3-ABA 3-Amino Benzamide 3-AB) is a potent inhibitor of Poly(ADP-ribose)polymerase (PARP) and inhibits cell apoptosis after SCI (Spinal Cord Injury) in caspase-independent way
Medchemexpress LLC Exatecan (mesylate) (GMP) | 169869-90-3 | 531.55 | 100 MG
Exatecan mesylate (DX8951f) GMP is a GMP-class Exatecan, a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
- DNA topoisomerase I inhibitor
- Potent antitumor activity against human tumors in vitro and in vivo
- Inhibits tumor growth in various cancer cell lines
- Prevents lung metastasis in orthotopic implantation mouse models
Medchemexpress LLC Dabrafenib (mesylate) | 1195768-06-9 | 99.9% | 615.67 | 50 MG
Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively. It is intended for research use.
- Inhibits over 90% of cell growth in NRAS mutant clones
- Reduces S6P phosphorylation in A375 cells
- Suppresses PolyP-mediated vascular barrier permeability
- Downregulates HMGB1-dependent inflammatory responses
- Enhances the expression of cell adhesion molecules (CAMs) in human endothelial cells
Medchemexpress LLC Purinostat mesylate | 2650188-32-0 | 99.5% | 586.62 | 5 MG
Purinostat mesylate is a selective inhibitor of HDAC, inhibiting class I and class IIb HDACs with IC50s ranging from 0.81 to 11.5 nM. It induces apoptosis and affects the cell cycle, demonstrating potent anti-leukemia effects in vivo. This product can be used for research on lymphoblastic leukemia.
- Selective inhibitor of HDAC
- Inhibits class I and class IIb HDACs
- Induces apoptosis
- Affects the cell cycle of LAMA84 and 188 BL-2 cells
- Demonstrates potent anti-leukemia effects in vivo
- Can be used for research on lymphoblastic leukemia
Medchemexpress LLC Masitinib mesylate | 1048007-93-7 | MFCD12546334 | 100.0% | 594.75 g/mol | C29H34N6O4S2 | 25 MG
Masitinib mesylate is a research-grade small-molecule tyrosine kinase inhibitor primarily targeting c-Kit and used in preclinical studies to assess antiproliferative and pro-apoptotic effects. It is supplied as a high-purity solid with documented solubility and storage recommendations for research use.
- Potent inhibitor of c-Kit with reported IC50 ≈ 200 nM.
- High reported purity suitable for analytical and biological studies.
- Supplied as a white to yellow solid with characterized physical properties.
- Documented solubility in DMSO and acidic aqueous media for formulation.
- Storage recommendations provided to preserve stability in solvent and solid form.
Medchemexpress LLC Pefloxacin mesylate | 70458-95-6 | 99.7% | 5 G
Pefloxacin mesylate is a broad-spectrum antibiotic that inhibits DNA replication by blocking DNA gyrase and DNA relaxation by topoisomerase I (IC50 of 45 μg/mL). It is effective against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis. This compound also shows anti-Plasmodium yoelii infection activity and is suitable for infection studies.
- Broad-spectrum antibiotic.
- Inhibits DNA gyrase and topoisomerase I.
- Active against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis.
- Effective against Plasmodium yoelii infections.
- Reduces bacterial load in gram-negative bacilli infections.
- Increases survival rate in Plasmodium yoelii-infected mice.